Adeleke R, Sahler J, Choi A, Roth K, Upadhye V, Ezzatpour S
Sci Adv. 2025; 11(5):eadq4545.
PMID: 39879304
PMC: 11777205.
DOI: 10.1126/sciadv.adq4545.
Haring C, Schroeder J, Jungwirth J, Loffler B, Henke A, Engert B
Front Microbiol. 2024; 15:1422651.
PMID: 39206370
PMC: 11350405.
DOI: 10.3389/fmicb.2024.1422651.
Rahikainen R, Rijal P, Tan T, Wu H, Andersson A, Barrett J
Angew Chem Weinheim Bergstr Ger. 2024; 133(1):325-334.
PMID: 38504824
PMC: 10947127.
DOI: 10.1002/ange.202009663.
AbuBakar U, Amrani L, Kamarulzaman F, Karsani S, Hassandarvish P, Khairat J
Viruses. 2023; 15(4).
PMID: 37112812
PMC: 10142937.
DOI: 10.3390/v15040833.
Yao C, Pan S, Xu Y, Lu M, Zhao Y, Huo J
J Virol. 2023; 97(3):e0004123.
PMID: 36916914
PMC: 10062136.
DOI: 10.1128/jvi.00041-23.
Message in a bottle: mRNA vaccination for influenza.
Shartouny J, Lowen A
J Gen Virol. 2022; 103(7).
PMID: 35830333
PMC: 10027004.
DOI: 10.1099/jgv.0.001765.
Production of Neuraminidase Virus Like Particles by Stably Transformed Insect Cells: A Simple Process for NA-Based Influenza Vaccine Development.
Khanefard N, Sapavee S, Akeprathumchai S, Mekvichitsaeng P, Poomputsa K
Mol Biotechnol. 2022; 64(12):1409-1418.
PMID: 35704162
PMC: 9198613.
DOI: 10.1007/s12033-022-00519-8.
An overview of influenza A virus genes, protein functions, and replication cycle highlighting important updates.
Chauhan R, Gordon M
Virus Genes. 2022; 58(4):255-269.
PMID: 35471490
DOI: 10.1007/s11262-022-01904-w.
Influenza Neuraminidase Characteristics and Potential as a Vaccine Target.
Creytens S, Pascha M, Ballegeer M, Saelens X, de Haan C
Front Immunol. 2021; 12:786617.
PMID: 34868073
PMC: 8635103.
DOI: 10.3389/fimmu.2021.786617.
Universal Influenza Virus Neuraminidase Vaccine Elicits Protective Immune Responses against Human Seasonal and Pre-pandemic Strains.
Skarlupka A, Bebin-Blackwell A, Sumner S, Ross T
J Virol. 2021; 95(17):e0075921.
PMID: 34160258
PMC: 8354223.
DOI: 10.1128/JVI.00759-21.
Overcoming Symmetry Mismatch in Vaccine Nanoassembly through Spontaneous Amidation.
Rahikainen R, Rijal P, Tan T, Wu H, Andersson A, Barrett J
Angew Chem Int Ed Engl. 2020; 60(1):321-330.
PMID: 32886840
PMC: 7821241.
DOI: 10.1002/anie.202009663.
Anti-Influenza Protective Efficacy of a H6 Virus-Like Particle in Chickens.
Zhu W, Wen Y, Lin S, Chen T, Chen H
Vaccines (Basel). 2020; 8(3).
PMID: 32825685
PMC: 7565593.
DOI: 10.3390/vaccines8030465.
Influenza A matrix protein M1 induces lipid membrane deformation via protein multimerization.
Dahmani I, Ludwig K, Chiantia S
Biosci Rep. 2019; 39(8).
PMID: 31324731
PMC: 6682550.
DOI: 10.1042/BSR20191024.
The 2nd sialic acid-binding site of influenza A virus neuraminidase is an important determinant of the hemagglutinin-neuraminidase-receptor balance.
Du W, Guo H, Nijman V, Doedt J, van der Vries E, van der Lee J
PLoS Pathog. 2019; 15(6):e1007860.
PMID: 31181126
PMC: 6586374.
DOI: 10.1371/journal.ppat.1007860.
Neuraminidase activity and specificity of influenza A virus are influenced by haemagglutinin-receptor binding.
Lai J, Karunarathna H, Wong H, Peiris J, Nicholls J
Emerg Microbes Infect. 2019; 8(1):327-338.
PMID: 30866786
PMC: 6455212.
DOI: 10.1080/22221751.2019.1581034.
Influenza A Virus Cell Entry, Replication, Virion Assembly and Movement.
Dou D, Revol R, Ostbye H, Wang H, Daniels R
Front Immunol. 2018; 9:1581.
PMID: 30079062
PMC: 6062596.
DOI: 10.3389/fimmu.2018.01581.
Influenza A Virus Hemagglutinin is Required for the Assembly of Viral Components Including Bundled vRNPs at the Lipid Raft.
Takizawa N, Momose F, Morikawa Y, Nomoto A
Viruses. 2016; 8(9).
PMID: 27626438
PMC: 5035963.
DOI: 10.3390/v8090249.
Protein-lipid interactions critical to replication of the influenza A virus.
Chlanda P, Zimmerberg J
FEBS Lett. 2016; 590(13):1940-54.
PMID: 26921878
PMC: 5007136.
DOI: 10.1002/1873-3468.12118.
Structural Analysis of the Roles of Influenza A Virus Membrane-Associated Proteins in Assembly and Morphology.
Chlanda P, Schraidt O, Kummer S, Riches J, Oberwinkler H, Prinz S
J Virol. 2015; 89(17):8957-66.
PMID: 26085153
PMC: 4524094.
DOI: 10.1128/JVI.00592-15.
Critical assessment of influenza VLP production in Sf9 and HEK293 expression systems.
Thompson C, Petiot E, Mullick A, Aucoin M, Henry O, Kamen A
BMC Biotechnol. 2015; 15:31.
PMID: 25981500
PMC: 4432999.
DOI: 10.1186/s12896-015-0152-x.